Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys-Reference-Cited by-同舟云学术

Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys

Published:2018-09 Issue:7 Volume:34 Page:531-537
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Fuwa Masahiro¹,Toris Carol B.²³,Fan Shan²,Taniguchi Takazumi¹,Ichikawa Masaki¹,Odani-Kawabata Noriko⁴,Iwamura Ryo⁵,Yoneda Kenji⁵,Matsugi Takeshi¹,Shams Naveed K.⁴⁶,Zhang Jin-Zhong¹⁶

Affiliation:

1. R&D Division, Santen Pharmaceutical Co., Ltd., Nara, Japan.

2. Department of Ophthalmology, Nebraska Medical Center, University of Nebraska Medical Center, Omaha, Nebraska.

3. Department of Ophthalmology, Case Western Reserve University, Cleveland, Ohio.

4. R&D Division, Santen Pharmaceutical Co., Ltd., Osaka, Japan.

5. Pharmaceuticals Research Laboratory, Pharmaceutical Division, Ube Industries, Ltd., Yamaguchi, Japan.

6. R&D Division, Santen, Inc., Emeryville, California.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

https://www.liebertpub.com/doi/pdf/10.1089/jop.2017.0146

Reference57 articles.

1. The number of people with glaucoma worldwide in 2010 and 2020

2. Glaucoma neuroprotection: What is it? Why is it needed?

3. Glaucoma

4. Glaucoma

5. Risk Factors for Glaucoma Onset and Progression

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3);American Journal of Ophthalmology;2024-07

2. Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial;Clinical Ophthalmology;2024-07

3. A Narrative Review of Pharmacotherapy of Glaucoma;Future Pharmacology;2024-05-27

4. Steroid-Induced Ocular Hypertension in Mice Is Differentially Reduced by Selective EP2, EP3, EP4, and IP Prostanoid Receptor Agonists;International Journal of Molecular Sciences;2024-03-15

5. Human experience and efficacy of omidenepag isopropyl (Eybelis®; Omlonti®): Discovery to approval of the novel non-prostaglandin EP2-receptor-selective agonist ocular hypotensive drug;Current Opinion in Pharmacology;2024-02